KKD Healthcare Analytics | TalkMarkets | Page 3
Healthcare Expert With 30 Years Experience
Contributor's Links: Dr KKD Healthcare Stock Tips

KKD Healthcare Analytics is a niche healthcare investment advisory service. Our goal is to channel our medical knowledge and long track record as a private investor into a website that will be the ultimate go-to place for knowledge and information about biotech ...more

All Contributions

Latest Posts
33 to 48 of 67 Posts
MannKind Corporation Reports Annual Net Profit
MannKind Corporation recently reported its financial results for the fourth quarter and full year. The company’s total revenue for the quarter stood at $12.4 million. Its net income for the quarter was reported at $54 million.
Vertex Pharmaceuticals Reports Positive Results From Two Trials
Vertex Pharmaceuticals stock jumped over 22 percent in its current trading session as it also created a new 52 weeks high of $111.88.
Verastem Creates New 52 Weeks High
Verastem stock has shown strong performance as it grew over 44 percent in the past 12 months.
Threshold Pharmaceuticals Inc. To Merge With Molecular Templates
Threshold Pharmaceuticals Inc. recently announced that it has agreed to merge with cancer-focused biopharmaceutical company Molecular Templates Inc. in an all-stock deal.
Array BioPharma Withdraws NDA For US Approval
Array BioPharma announced that it has withdrawn its New Drug Application (NDA) in the U.S. seeking approval of binimetinib for the treatment of NRAS mutation-positive melanoma, a rare subtype of skin cancer.
Ionis Pharmaceuticals Reports Positive Trial Results
Ionis Pharmaceuticals announced that the pivotal Phase 3 APPROACH study of volanesorsen met its primary endpoint of reducing triglyceride levels in patients with familial chylomicronemia syndrome.
Amgen Reports Positive Results For Leukemia Drug
Amgen Inc. reported the results of the Phase 3 study of its leukemia drug Blincyto (blinatumomab).
Exact Sciences Reports Positive Results From Lung Cancer Test Study
Exact Sciences Corporation reported that its collaboration with Mayo Clinics for developing a blood-based lung cancer test shows promising prospects.
Pfizer Receives Warning Letter From The FDA
Pfizer Inc. reported that the company has received a warning letter from the FDA regarding its operations at a plant in McPherson, Kansas.
Laboratory Corp. Of America Holdings To Buy Pathology Associates Medical Laboratories
Laboratory Corp. of America Holdings announced its plans to acquire Pathology Associates Medical Laboratories LLC from Providence Health & Services and Catholic Health Initiatives.
Gilead Sciences Receives Canadian Approval For HIV Drug
Gilead Sciences Inc. announced that it has received approval in Canada for its Odefsey for treating HIV-1 infection.
AstraZeneca Reports Positive Phase 2 Results For Cancer Drug
The company stock has gained over 5 percent this year so far. Its 12 months performance is a little shaky as the stock lost 3 percent of its value during this time period.
Cigna Terminates Deal With Anthem, To Sue For Damages
Cigna Corporation announced that it has terminated its merger agreement with Anthem.
Inovio Inks New Deal With ApolloBio Corporation
Inovio Pharmaceuticals Inc. announced its new collaboration with ApolloBio Corporation.
Acorda Therapeutics Reports Positive CVT-301 Results
Acorda Therapeutics announced the results from a late-stage clinical trial of the drug candidate, CVT-301.
Benitec Biopharma Pursues Oncology And Ocular Trials
Benitec Biopharma announced that it has significant milestone with regard to its ddRNAi technology to treat ocular diseases, particularly with identifying novel viral vectors.
33 to 48 of 67 Posts